C42H66FeN4O6, orthorhombic, P212121 (no. 19), a = 10.7723(9) Å, b = 11.7128(8) Å, c = 33.392(3) Å, V = 4213.2 Å3, Z = 4, Rgt(F) = 0.071, wRref(F2) = 0.158, T = 193 K
C49H40BCu2F4Fe2N5O5, triclinic, P1̄ (no. 2), a = 11.526(2) Å, b = 12.902(2) Å, c = 15.469(3) Å, α = ...
The title iron(II) complex, [Fe(C16H12NO2)2], crystallizes in the orthorhombic space group Pbca with...
Biferrocenyi, C₅H₅,Fe,C₅H₄. C₅H₄ .Fe.C₅H₅., crystallises in the monoclinic system with a = 10.35, b ...
C13H12FeN2O, monoclinic, P21/n (no. 14), a = 5.9035(2) Å, b = 20.7111(6) Å, c = 9.1403(3) Å, β = 90....
C21H21FeNO, monoclinic, P121/a1 (no. 14), a = 7.329(7) Å, b = 17.343(3) Å, c = 13.618(5) Å, ? = 95.0...
WOS: 000234198700025C21H21FeNO, monoclinic, P12(1)/alpha 1 (no. 14), a = 7.329(7) angstrom, b = 17.3...
C40H44CuO4Fe2N6, triclinic, P1̄ (no. 2), a = 7.4758(4) Å, b = 7.7447(5) Å, c = 16.2929(10) Å, α = 87...
The title iron(II) complex, [Fe(C16H12NO2)2], crystallizes in the ortho-rhom-bic space group Pbca wi...
C22H18ClN2FeO4, monoclinic, P21/n (no. 14), a = 7.0779(6) Å, b = 19.0203(16) Å, c = 14.7233(12) Å, β...
C19H17FeN3O4S, triclinic, P1̄ (no. 2), a = 7.1964(3) Å, b = 10.9732(4) Å, c = 11.6391(4) Å, α = 80.8...
C17H14FeN4, monoclinic, P21/c, a = 11.8213(11) Å, b = 10.3610(10) Å, c = 11.8552(11) Å, α = γ = 90°,...
C31H33N2O3, orthorhombic, P212121 (no. 19), a = 7.8122(11) Å, b = 12.2682(18) Å, c = 28.837(4) Å, V ...
The title compound, [Fe(C7H9N2)2], crystallizes with two crystallographically independent molecules ...
C23H19FeN3O3S, monoclinic, P21/n (no. 14), a = 13.1372(6) Å, b = 9.6866(5) Å, c = 15.9700(8) Å, β = ...
C16H13FeN3O2S, triclinic, P1̅, a = 8.1311(9) Å, b = 11.6852(13) Å, c = 17.044(2) Å, α = 102.754(6)°,...
C49H40BCu2F4Fe2N5O5, triclinic, P1̄ (no. 2), a = 11.526(2) Å, b = 12.902(2) Å, c = 15.469(3) Å, α = ...
The title iron(II) complex, [Fe(C16H12NO2)2], crystallizes in the orthorhombic space group Pbca with...
Biferrocenyi, C₅H₅,Fe,C₅H₄. C₅H₄ .Fe.C₅H₅., crystallises in the monoclinic system with a = 10.35, b ...
C13H12FeN2O, monoclinic, P21/n (no. 14), a = 5.9035(2) Å, b = 20.7111(6) Å, c = 9.1403(3) Å, β = 90....
C21H21FeNO, monoclinic, P121/a1 (no. 14), a = 7.329(7) Å, b = 17.343(3) Å, c = 13.618(5) Å, ? = 95.0...
WOS: 000234198700025C21H21FeNO, monoclinic, P12(1)/alpha 1 (no. 14), a = 7.329(7) angstrom, b = 17.3...
C40H44CuO4Fe2N6, triclinic, P1̄ (no. 2), a = 7.4758(4) Å, b = 7.7447(5) Å, c = 16.2929(10) Å, α = 87...
The title iron(II) complex, [Fe(C16H12NO2)2], crystallizes in the ortho-rhom-bic space group Pbca wi...
C22H18ClN2FeO4, monoclinic, P21/n (no. 14), a = 7.0779(6) Å, b = 19.0203(16) Å, c = 14.7233(12) Å, β...
C19H17FeN3O4S, triclinic, P1̄ (no. 2), a = 7.1964(3) Å, b = 10.9732(4) Å, c = 11.6391(4) Å, α = 80.8...
C17H14FeN4, monoclinic, P21/c, a = 11.8213(11) Å, b = 10.3610(10) Å, c = 11.8552(11) Å, α = γ = 90°,...
C31H33N2O3, orthorhombic, P212121 (no. 19), a = 7.8122(11) Å, b = 12.2682(18) Å, c = 28.837(4) Å, V ...
The title compound, [Fe(C7H9N2)2], crystallizes with two crystallographically independent molecules ...
C23H19FeN3O3S, monoclinic, P21/n (no. 14), a = 13.1372(6) Å, b = 9.6866(5) Å, c = 15.9700(8) Å, β = ...
C16H13FeN3O2S, triclinic, P1̅, a = 8.1311(9) Å, b = 11.6852(13) Å, c = 17.044(2) Å, α = 102.754(6)°,...
C49H40BCu2F4Fe2N5O5, triclinic, P1̄ (no. 2), a = 11.526(2) Å, b = 12.902(2) Å, c = 15.469(3) Å, α = ...
The title iron(II) complex, [Fe(C16H12NO2)2], crystallizes in the orthorhombic space group Pbca with...
Biferrocenyi, C₅H₅,Fe,C₅H₄. C₅H₄ .Fe.C₅H₅., crystallises in the monoclinic system with a = 10.35, b ...